Terry Vuong, DO
Obesity Medicine · Syosset, NYNPI 1700317195
Payments from drug & device makers
Across 436 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- GSK$601
- Idorsia Pharmaceuticals US Inc$557
- Lilly USA, LLC$549
- Amgen$525
- plus $4K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,527 |
| Novo Nordisk | 50 | $1,225 |
| GSK | 35 | $601 |
| Idorsia Pharmaceuticals US Inc | 27 | $557 |
| Lilly USA, LLC | 27 | $549 |
| Amgen | 32 | $525 |
| Bayer | 20 | $516 |
| AstraZeneca | 20 | $496 |
| Merck | 23 | $482 |
| Astellas Pharma US Inc | 20 | $382 |
| Exact Sciences | 16 | $374 |
| Scilex Pharmaceuticals Inc. | 17 | $358 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $247 |
| Axsome Therapeutics, Inc. | 9 | $244 |
| Johnson & Johnson | 5 | $182 |
| Boehringer Ingelheim | 6 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $123 |
| Pfizer | 5 | $119 |
| Novartis | 5 | $93 |
| Viiv Healthcare Company | 3 | $90 |
| Amneal Pharmaceuticals LLC | 3 | $70 |
| Eisai Inc. | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| Abbott | 2 | $46 |
| Renalytix AI, Inc. | 2 | $45 |
| Vivus LLC | 2 | $35 |
| Corcept Therapeutics | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
Too few obesity medicine providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obesity medicine in Syosset
- Holly LoftonNew York$3.2M
- Barbara ConnorSyracuse$1.7M
- Jessica WitteOlean$7K
- Sarah SchmitzNew York$3K
- Duane FredericksNew York$3K
- Carol SantoroAlbany$1K
- Anelise EngelNew York$750
- Carl RuoffRoslyn Heights$348
- Thomas DoboszBuffalo$201
- Maysaa HameedRochester$187
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.